Mehta Joins The Column Group: A New Venture Partner

People | Nov 02, 2024 | Column Group LLC/The

The Column Group, a prominent private equity firm, has announced the induction of Dr. Arnav Mehta as a Venture Partner. Dr. Mehta boasts an extensive background in oncology, having served at the Massachusetts General Hospital Cancer Center and the Broad Institute, where he led cutting-edge research programs. Additionally, as an Entrepreneur-in-Residence at Third Rock Ventures, Dr. Mehta played an instrumental role in founding innovative biotech companies such as Abata Therapeutics, Asher Biotherapeutics, and Clasp Therapeutics. His expertise in both clinical applications and research methodologies, particularly in gastrointestinal tumor immunology and pancreatic cancer, will undoubtedly enhance The Column Group's investment strategy and portfolio development within the biotechnology sector.

Sectors

Biotechnology
Private Equity

Geography

United States – The article and participants, including The Column Group, Massachusetts General Hospital, Broad Institute, and Third Rock Ventures, are based in the United States.

Industry

Biotechnology – The article focuses on Venture Partner hiring involving Dr. Mehta, who has a strong background in biotechnology, particularly in cancer research and therapeutic development.
Private Equity – The Column Group is a private equity firm focusing on investments in the biotechnology sector, as evidenced by its hiring of Dr. Mehta to enhance strategic decision-making.

Financials

Participants

Name	Role	Type	Description
Dr. Arnav Mehta	Venture Partner	Person	An oncologist and biotech entrepreneur, previously affiliated with Third Rock Ventures, Massachusetts General Hospital, and the Broad Institute.
The Column Group	Private Equity Firm	Company	A private equity firm focusing on biotechnology investments, which has hired Dr. Arnav Mehta as a Venture Partner.
Third Rock Ventures	Former Employer	Company	A venture capital firm where Dr. Mehta worked as an Entrepreneur-in-Residence, contributing to the founding of several biotech companies.
Massachusetts General Hospital Cancer Center	Research Institution	Company	A medical center where Dr. Mehta focused on gastrointestinal tumor immunology.
Broad Institute	Research Institution	Company	An institution where Dr. Mehta led research on pancreatic cancer using advanced genomics and imaging techniques.